Covance Inc. (CVD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Joseph L. Herring
Employees:
12,501
210 CARNEGIE CENTER, PRINCETON, NJ 08540
6094524440

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Covance Inc., a drug development services company, provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries worldwide.

Data derived from most recent annual or quarterly report
Market Cap 6.062 Billion Shares Outstanding56.96 Million Avg 30-day Volume 1.231 Million
P/E Ratio25.0299 Dividend Yield0.0 EPS2.41
Price to Revenue1.6685 Debt to Equity0.1516 EBITDA364.148 Million
Price to Book Value2.7258 Operating Margin8.0775 Enterprise Value4.04 Billion
Current Ratio2.794 EPS Growth0.047 Quick Ratio2.2
1 Yr BETA 0.7193 52-week High/Low 0.0 / Profit Margin6.6662
Operating Cash Flow Growth1.6579 Free Cash Flow to Firm (FCFF) TTM 154.335 Million Free Cash Flow to Equity (FCFE) TTM528.849 Million
Altman Z-Score5.9361
View SEC Filings from CVD instead.

View recent insider trading info

Funds Holding CVD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CVD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCCARTNEY JOHN

  • Director
No longer subject to file 2015-02-19 0

HELTON SANDRA L

  • Director
No longer subject to file 2015-02-19 0

SHEARES BRADLEY T

  • Director
No longer subject to file 2015-02-19 0

COSTLEY GARY E

  • Director
No longer subject to file 2015-02-19 0

HERRING JOSEPH L CHAIRMAN AND CEO

  • Officer
  • Director
0 2015-02-19 0

KLITGAARD WILLIAM E CORPORATE SR. VICE PRESIDENT

  • Officer
0 2015-02-19 0

LOVETT JAMES W CORPORATE SR. VICE PRESIDENT

  • Officer
0 2015-02-19 0

BARCHI ROBERT

  • Director
No longer subject to file 2015-02-19 0

CIMINO RICHARD F CORP. EXECUTIVE VICE PRESIDENT

  • Officer
0 2015-02-19 0

SCODARI JOSEPH C

  • Director
No longer subject to file 2015-02-19 0

KELLER DEBORAH L CORP. EXECUTIVE VICE PRESIDENT

  • Officer
0 2015-02-19 0

WATSON JOHN E. CORP. SR. VICE PRESIDENT

  • Officer
0 2015-02-19 0

NUTT BRIAN H. PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2015-02-19 0

CORNELL ALISON A CORPORATE SENIOR VP AND CFO

  • Officer
0 2015-02-19 0

LEHMANN MICHAEL J. CORP. SR. VICE PRESIDENT

  • Officer
14,582 2011-02-17 0

BANG KATHLEEN G

  • Director
2,000 2011-01-03 0

BARR WENDEL EXECUTIVE VICE PRESIDENT & COO

  • Officer
54,768 2010-12-20 0

KRAFT DONALD CORPORATE SR. VICE PRESIDENT

  • Officer
47,084 2010-06-21 0

KENNEDY MICHELE A CORP VICE PRESIDENT

  • Officer
3,659 2009-02-23 0

LERNER IRWIN

  • Director
13,200 2009-01-02 0

CORK ANTHONY CORP. SR. VICE PRESIDENT

  • Officer
37,742 2008-12-19 0

MACDONALD J RANDALL

  • Director
5,100 2008-05-08 0

UGHETTA WILLIAM C

  • Director
49,598 2008-02-04 0

GIANNETTO MICHAEL CORPORATE VICE PRESIDENT

  • Officer
5,014 2007-02-22 0

BAYLIS ROBERT M

  • Director
14,400 2007-01-03 0

SULLIVAN STEPHEN J CORPORATE SR. VICE PRESIDENT

  • Officer
71,414 2006-02-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments